LD 659 LR 762(01)
An Act Regarding the Use of Interchangeable Biological Products
Preliminary Fiscal Impact Statement for Original Bill
Sponsor: Rep. Perry of Calais
Committee: Health Coverage, Insurance and Financial Services
Fiscal Note Required: No
Preliminary Fiscal Impact Statement
Minor cost increase - Other Special Revenue Funds
Fiscal Detail and Notes
Additional costs to the Board of Pharmacy within the Department of Professional and Financial Regulation, Office of Professional and Occupational Regulation, to provide the required link on its publicly accessible website can be absorbed within existing budgeted resources.